Detection of inflamed atherosclerotic lesions with diadenosine-5′,5‴-P1,P4-tetraphosphate (Ap4A) and positron-emission tomography

Diadenosine-5′,5‴-P1,P4-tetraphosphate (Ap4A) and its analog P2,P3-monochloromethylene diadenosine-5′,5‴-P1,P4-tetraphosphate (AppCHClppA) are competitive inhibitors of adenosine diphosphate-induced platelet aggregation, which plays a central role in arterial thrombosis and plaque formation. In this study, we evaluate the imaging capabilities of positron-emission tomography (PET) with P2,P3-[18F]monofluoromethylene diadenosine-5′,5‴-P1,P4-tetraphosphate ([18F]AppCHFppA) to detect atherosclerotic lesions in male New Zealand White rabbits. Three to six months after balloon injury to the aorta, the rabbits were injected with [18F]AppCHFppA, and microPET imaging showed rapid accumulation of this radiopharmaceutical in the atherosclerotic abdominal aorta, with lesions clearly visible 30 min after injection. Computed tomographic images were coregistered with PET images to improve delineation of aortoiliac tracer activity. Plaque macrophage density, quantified by immunostaining with RAM11 against rabbit macrophages, correlated with PET measurements of [18F]AppCHFppA uptake (r = 0.87, P < 0.0001), whereas smooth-muscle cell density, quantified by immunostaining with 1A4 against smooth muscle actin, did not. Biodistribution studies of [18F]AppCHFppA in normal rats indicated typical adenosine dinucleotide behavior with insignificant myocardial uptake and fast kidney clearance. The accumulation of [18F]AppCHFppA in macrophage-rich atherosclerotic plaques can be quantified noninvasively with PET. Hence, [18F]AppCHFppA holds promise for the noninvasive characterization of vascular inflammation.

[1]  T. Palmer,et al.  Adenosine receptors and the control of endothelial cell function in inflammatory disease. , 2005, Immunology letters.

[2]  S. Narula,et al.  The pyrimidinergic P2Y6 receptor mediates a novel release of proinflammatory cytokines and chemokines in monocytic cells stimulated with UDP. , 2005, Biochemical and biophysical research communications.

[3]  J. Boeynaems,et al.  Overview of the P2 receptors. , 2005, Seminars in thrombosis and hemostasis.

[4]  Matthew R. Jones,et al.  Animal models for the study of adenosine receptor function , 2005, Journal of cellular physiology.

[5]  M. E. Kooi,et al.  Accumulation of Ultrasmall Superparamagnetic Particles of Iron Oxide in Human Atherosclerotic Plaques Can Be Detected by In Vivo Magnetic Resonance Imaging , 2003, Circulation.

[6]  Samuel A Wickline,et al.  Nanotechnology for molecular imaging and targeted therapy. , 2003, Circulation.

[7]  S. Tsimikas.  Noninvasive imaging of oxidized low-density lipoprotein in atherosclerotic plaques with tagged oxidation-specific antibodies. , 2002, The American journal of cardiology.

[8]  V. Fuster,et al.  Computed Tomography and Magnetic Resonance Imaging for Noninvasive Coronary Angiography and Plaque Imaging: Current and Potential Future Concepts , 2002, Circulation.

[9]  Eliana Gianolio,et al.  Insights into the use of paramagnetic Gd(III) complexes in MR‐molecular imaging investigations , 2002, Journal of magnetic resonance imaging : JMRI.

[10]  J. Pickard,et al.  Imaging Atherosclerotic Plaque Inflammation With [18F]-Fluorodeoxyglucose Positron Emission Tomography , 2002, Circulation.

[11]  N. Flavahan,et al.  Activated Monocytes Induce Smooth Muscle Cell Death: Role of Macrophage Colony-Stimulating Factor and Cell Contact , 2002, Circulation.

[12]  R. Wahl,et al.  Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG) , 2001, Nuclear medicine communications.

[13]  P. Yock,et al.  Intravascular ultrasound: novel pathophysiological insights and current clinical applications. , 2001, Circulation.

[14]  J. Fujimoto,et al.  Assessment of coronary plaque with optical coherence tomography and high-frequency ultrasound. , 2000, The American journal of cardiology.

[15]  S. L. Bridal,et al.  Imagerie non invasive de l'athérosclérose en IRM et échographie , 1999 .

[16]  T. Callister,et al.  Coronary artery disease: improved reproducibility of calcium scoring with an electron-beam CT volumetric method. , 1998, Radiology.

[17]  H. Steinmetz,et al.  Inflammation in high-grade carotid stenosis: a possible role for macrophages and T cells in plaque destabilization. , 1998, Stroke.

[18]  A. Fischman,et al.  Rapid noninvasive detection of experimental atherosclerotic lesions with novel 99mTc-labeled diadenosine tetraphosphates. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[19]  V. Torchilin,et al.  Noninvasive localization of experimental atherosclerotic lesions with mouse/human chimeric Z2D3 F(ab')2 specific for the proliferating smooth muscle cells of human atheroma. Imaging with conventional and negative charge-modified antibody fragments. , 1995, Circulation.

[20]  V. Torchilin.  Handbook of targeted delivery of imaging agents , 1995 .

[21]  P. Zamecnik,et al.  Analogues of diadenosine 5',5'''-P1,P4-tetraphosphate (Ap4A) as potential anti-platelet-aggregation agents. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[22]  B. Sobel,et al.  Imaging of Thrombi With Tissue‐Type Plasminogen Activator Rendered Enzymatically Inactive and Conjugated to a Residualizing Label , 1992, Circulation.

[23]  A. McLennan.  Ap4A and Other Dinucleoside Polyphosphates , 1992 .

[24]  E. Butcher.  Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity , 1991, Cell.

[25]  J. Thyberg,et al.  Regulation of differentiated properties and proliferation of arterial smooth muscle cells. , 1990, Arteriosclerosis.

[26]  R. Ahmadi,et al.  Indium-111-labeled platelet scintigraphy in carotid atherosclerosis. , 1989, Stroke.

[27]  R. Ross.  The pathogenesis of atherosclerosis--an update. , 1986, The New England journal of medicine.

[28]  E. Rapaport,et al.  99mTc-labeled nucleotides as tumor-seeking radiodiagnostic agents. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Gary R. Grotendorst,et al.  Attachment of smooth muscle cells to collagen and their migration toward platelet-derived growth factor. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Welch,et al.  Scintigraphic Detection of Carotid Atherosclerosis with Indium‐111‐labeled Autologous Platelets , 1980, Circulation.

[31]  K. Ericson,et al.  DETECTION OF ATHEROSCLEROTIC PLAQUES IN CAROTID ARTERIES BY THE USE OF 123I-FIBRINOGEN , 1978, The Lancet.

[32]  H. Baumgartner.  Eine neue Methode zur Erzeugung von Thromben durch gezielte Überdehnung der Gefäßwand , 1963 .